{"name":"Mirror Biologics, Inc.","slug":"mirror-biologics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"AlloStim-7","genericName":"AlloStim-7","slug":"allostim-7","indication":"Other","status":"phase_1"},{"name":"AlloStim8 or AlloStim-9","genericName":"AlloStim8 or AlloStim-9","slug":"allostim8-or-allostim-9","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AlloStim-7","genericName":"AlloStim-7","slug":"allostim-7","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"AlloStim8 or AlloStim-9","genericName":"AlloStim8 or AlloStim-9","slug":"allostim8-or-allostim-9","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxPSlFhcVdwaFlONm5LenM3akJpY2hmc04zT3hMeWFVMm50ZTBMTWNZNlFWRFBUOUdJZ010blhQNkpKR1gzd2NwN0lDOXFRQlFQVmZZSW82aDRiYU94a3VaZDkxWWsxTWJGUEJlNnJWa1pGV2FEZkFLX3QyVWJJSDQ2ajgxZnVQY25wZnloZ3RBOVR4RGhSZ1REYjhHWGhzeTlmVjFmbEQ5b1ZSTktKQzltVDM0bHdBNm1DSEM2S1VSbEl0a0QybjUzZE5laFF2YTFqSkZNYlVrdXBKQm9lVjlZTTZiSDMwa3YzMUgwaHAxeV82LVNKZTFoZUI5ZG1NbThqUlE5bEFBUWJ6Rm5XcVV5Q2VWNl9NREdCN2lycUhOU2otUEh6NDBmSERtS3VPaENoMnI3M0tKRmxmTjg?oc=5","date":"2025-05-13","type":"trial","source":"GlobeNewswire","summary":"Metastatic Colorectal Cancer Clinical Trial Pipeline - GlobeNewswire","headline":"Metastatic Colorectal Cancer Clinical Trial Pipeline","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOX0YwRmZLX2tiZm5fazluNGdlQTNrX08xVzNuNEZFS3dqU3lhbWJHR01TbnFSVEFNSkRXWVNSZlg1Uk5OWF9McHVIS0VYam9QTG9xN3lUWjFQcGlMVC1KUDNuMmhndm1HSW5OaXJzQWRUR09xVWY5eEpzS2x1MklybHp4bWk2b3FVaXdzZlJYSl9CcWFCRUpXdG5Rd2Z2TWVmMFFONE5zaW5EeXdHTGR1UUtmSkNsRHVGMnBxcE9YRmxlZllkQjdvQ3lPMFdnNFRBaWthZGtyV3lxWlhPUlpEQUJRR3o0Vms?oc=5","date":"2025-01-09","type":"deal","source":"BioSpace","summary":"Mirror Biologics Enters Clinical Collaboration with Merck KGaA, Darmstadt, Germany in Metastatic Colorectal Cancer - BioSpace","headline":"Mirror Biologics Enters Clinical Collaboration with Merck KGaA, Darmstadt, Germany in Metastatic Colorectal Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE04aHdyUFBxSjAwRlVPcENpQTUzNER0QlBWUmE1WEZxRzRCX3ZQTWNiYWRWYWw3bGxaMUFjV2Vva2pyTm12c2dETGN3d0F5Wm5S?oc=5","date":"2024-04-18","type":"pipeline","source":"PR.com","summary":"Mirror Biologics, Inc. Appoints Elizabeth Czerepak as Chief Financial Officer and VP Corporate Development - PR.com","headline":"Mirror Biologics, Inc. Appoints Elizabeth Czerepak as Chief Financial Officer and VP Corporate Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNdG1Ublo2U0RHYjNfdkJxRkdGbi00TmRHY1g1VjFpdE5mbXBDbzBVMEYyajVxRk53LUh4M19LbHZOREJWalg5Mmk4UWtSSTNadGlEOUtUbnoyaG5qYlNtc2lLdmhpZWdXd1lJb05yVy14NXNuT0V0ZFRQbG12WEpRT1B0UHNzU3ptLUp3ZGlHV3c?oc=5","date":"2023-09-07","type":"pipeline","source":"Yahoo Finance","summary":"Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer - Yahoo Finance","headline":"Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNUHp1aFlxcDFVTzlKdFl2R0RuUXNzNnE4RVdNNFM2NUdHYV9UczhDUlkwcEMweXZPb0xWWGR5NWljUng2RmFKVGpwOTVOZlExdHJTNDBlTlZBV0Y5dW1XMTBRYldQMjV3dDlXNEttUjctR3YwNXdGeDFBU0NSdkFLdGlQYUlNbWZHdHZNZEtnNXRWVmtnTXBzUg?oc=5","date":"2022-05-13","type":"pipeline","source":"PharmaLive","summary":"Universal Antivirals Could be the Future for Preventing Pandemics - PharmaLive","headline":"Universal Antivirals Could be the Future for Preventing Pandemics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE5yWnU5SWdjVUZqMUJXQ3pYQVFFUjRQandod1FjUHZhSWZpT1B6Mng4Nko2WDFvLUQ1UEtOcm5feWNkU3FWNERmcDY3anJyZkJt?oc=5","date":"2021-07-09","type":"trial","source":"PR.com","summary":"Mirror Biologics, Inc. Announces Initiation of AlloStim® Phase IIB Clinical Trial (STIMVAX) in Patients with Metastatic Colorectal Cancer - PR.com","headline":"Mirror Biologics, Inc. Announces Initiation of AlloStim® Phase IIB Clinical Trial (STIMVAX) in Patients with Metastatic ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOMUtZSHhRV1gxX3IwZTRWUmZuek1VcFZUZXFRVHBkT1VpZDR3bEx5NmRwNFlKbllIbTRmT1VyMjdTYVRoTFEySGdPZVFyLVZGYWVwS211WXRfU1N0a2IyeFktMHlsaG5IRjFURzh5MS16NGZzeTdDTnRUVmQ3Tk8zZWMzSnJLUF9fSmpXbGhDUE5Bb01Oc0hPUHJnY29ja1VTb0tJ?oc=5","date":"2017-09-21","type":"pipeline","source":"Clinical Leader","summary":"Clinical Challenges In Pet Meds Mirror Those In Human Studies - Clinical Leader","headline":"Clinical Challenges In Pet Meds Mirror Those In Human Studies","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}